Published August 27, 2023 | Version Submitted
Discussion Paper Open

Cadherin Adhesion Complexes Direct Cell Aggregation in the Epithelial Transition of Wnt-Induced Nephron Progenitor Cells

  • 1. ROR icon University of Southern California
  • 2. ROR icon Semmelweis University
  • 3. ROR icon Icahn School of Medicine at Mount Sinai

Abstract

In the developing mammalian kidney, nephron formation is initiated by a subset of nephron progenitor cells (NPCs). Wnt input activates a β-catenin (Ctnnb1)-driven, transcriptional nephrogenic program. In conjunction, induced mesenchymal NPCs transition through a pre-tubular aggregate to an epithelial renal vesicle, the precursor for each nephron. How this critical mesenchymal-to-epithelial transition (MET) is regulated is unclear. In an in vitro mouse NPC culture model, activation of the Wnt pathway results in the aggregation of induced NPCs into closely-packed, cell clusters. Genetic removal of β-catenin resulted in a failure of both Wnt pathway-directed transcriptional activation and the formation of aggregated cell clusters. Modulating extracellular Ca2+ levels showed cell-cell contacts were Ca2+-dependent, suggesting a role for cadherin (Cdh)-directed cell adhesion. Molecular analysis identified Cdh2Cdh4 and Cdh11 in uninduced NPCs and the up-regulation of Cdh3 and Cdh4 accompanying the Wnt pathway-induced MET. Genetic removal of all four cadherins, and independent removal of α-catenin, which couples Cdh-β-catenin membrane complexes to the actin cytoskeleton, abolished cell aggregation in response to Wnt pathway activation. However, the β-catenin driven inductive transcriptional program was unaltered. Together with the accompanying paper (Bugacov et al., submitted), these data demonstrate that distinct cellular activities of β-catenin - transcriptional regulation and cell adhesion - combine in the mammalian kidney programs generating differentiated epithelial nephron precursors from mesenchymal nephron progenitors.

Copyright and License

The copyright holder for this preprint is the author/funder. All rights reserved. No reuse allowed without permission.

Conflict of Interest

APM is a consultant or scientific advisor to Novartis, eGENESIS, Trestle Biotherapeutics and IVIVA Medical. Other authors declare no conflict of interest.

Supplemental Material

Files

2023.08.27.555021v1.full.pdf

Files (72.9 MB)

Name Size
md5:c5a8a41cafb5322be3cffa1bc1d38be7
6.3 MB Preview Download
md5:c11de2a4c70e1d691408a1ccd2589cd5
581.9 kB Download
md5:0c3f5ad351b3a426ea6363f62237ed38
14.4 kB Download
md5:66a98333d4a01a481d82723f6fd4bc63
31.1 MB Preview Download
md5:c6e1354f020e5e7dc1774842641c5c34
30.3 MB Preview Download
md5:6c02e99ec0da2e8713218079079df242
4.5 MB Preview Download

Additional details

Related works

Caltech Custom Metadata